Treatment of Ovarian Carcinoma: Possibilities for Progress

Abstract

OVARIAN carcinoma is the fourth most frequent cause of death from cancer among women.¹ Approximately 14,000 new cases are diagnosed each year, of which 10,000 will eventually be fatal.¹ In about 1/2 of all patients, the tumor is amenable to primary resection. However, even after what appears to be complete removal of the disease, a recurrence requiring further treatment will develop in about 20 to 50 per cent of these cases.^{2 , 3} Radiation therapy has been extensively used as an adjunct to primary surgery. Gratifying results have been achieved in many patients, especially with localized disease, but the limited success with . . .